Your browser doesn't support javascript.
loading
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 study.
Psyrri, A; Fortpied, C; Koutsodontis, G; Avgeris, M; Kroupis, C; Goutas, N; Menis, J; Herman, L; Giurgea, L; Remenár, É; Degardin, M; Pateras, I S; Langendijk, J A; van Herpen, C M L; Awada, A; Germà-Lluch, J R; Kienzer, H R; Licitra, L; Vermorken, J B.
Affiliation
  • Psyrri A; Section of Medical Oncology, Second Department of Internal Medicine, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Fortpied C; EORTC Headquarters, Brussels, Belgium.
  • Koutsodontis G; Section of Medical Oncology, Second Department of Internal Medicine, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Avgeris M; Department of Biochemistry and Molecular Biology, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.
  • Kroupis C; Department of Clinical Biochemistry, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Goutas N; Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Menis J; EORTC Headquarters, Brussels, Belgium.
  • Herman L; EORTC Headquarters, Brussels, Belgium.
  • Giurgea L; EORTC Headquarters, Brussels, Belgium.
  • Remenár É; Department of Head and Neck Surgery, National Institute of Oncology, Budapest, Hungary.
  • Degardin M; Department of Oncology, Centre Oscar Lambret, Lille, France.
  • Pateras IS; Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Langendijk JA; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • van Herpen CML; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Awada A; Medical Oncology Clinic, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium.
  • Germà-Lluch JR; Institut Català d'Oncologia, ICO L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Kienzer HR; 3rd Medical Department, Oncology and Hematology Center, Kaiser Franz Josef Spital/SMZ Sud, Vienna, Austria.
  • Licitra L; Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, and University of Milan, Milan, Italy.
  • Vermorken JB; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.
Ann Oncol ; 28(9): 2213-2218, 2017 Sep 01.
Article de En | MEDLINE | ID: mdl-28651338

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Papillomaviridae / Carcinome épidermoïde / Protocoles de polychimiothérapie antinéoplasique / Cisplatine / Taxoïdes / Fluorouracil / Tumeurs de la tête et du cou Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Papillomaviridae / Carcinome épidermoïde / Protocoles de polychimiothérapie antinéoplasique / Cisplatine / Taxoïdes / Fluorouracil / Tumeurs de la tête et du cou Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Female / Humans / Male Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Royaume-Uni